Ruprofen

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Ruprofen

Property Description
Active ingredient Ibuprofen
Form Oral Solid (e.g., tablets, capsules), Oral Liquid (suspension)
Pharmacological class Nonsteroidal Anti-inflammatory Drug (NSAID)
Common purpose Pain, fever, and inflammation relief
Origin Synthetic, propionic acid derivative

What Type of Medicine is Ruprofen?

Ruprofen is a pharmaceutical preparation whose active ingredient is Ibuprofen, classifying it as a Nonsteroidal Anti-inflammatory Drug (NSAID). This medicine is a synthetic compound that belongs specifically to the propionic acid derivative group. Ibuprofen is recognized as a well-established substance for symptomatic relief, a classification supported by pharmacological studies. The drug entity, Ruprofen, is typically formulated as a single active ingredient product and is widely available in several forms, including common oral solid preparations such as tablets and capsules, designed for oral route of administration.


Ruprofen's Core Composition and General Purpose

The core composition of Ruprofen relies on the active ingredient Ibuprofen, which is clinically recognized for interrupting the body’s inflammatory cascade to achieve its general purpose. The chemical substance is supplied as a racemic mixture containing both S- and R-enantiomers, which is a key molecular characteristic of the ingredient. The general purpose of the medication is to provide relief from the three main symptoms of illness and injury: pain, elevated body temperature (fever), and inflammation. It achieves this by working internally to reduce the production of chemical messengers—specifically prostaglandins—that are responsible for generating these symptoms. This systemic action is typically employed for common discomforts such as a headache or temporary stiffness.


Who is Ruprofen Designed For?

Ruprofen preparations are designed for a broad target audience, including both adults and children, due to its availability in various drug forms. To suit diverse patient needs, the product is supplied not only as solid preparations for adults but also in oral liquid preparations like suspension, often manufactured to facilitate administration for the pediatric patient group. While many common forms are available as non-prescription (OTC) strength, specialized or higher-concentration preparations may require a prescription, aligning the product's strength with the severity of the patient's condition.

Regulatory References

  1. Ibuprofen: MedlinePlus Drug Information
  2. Ibuprofen- and dexibuprofen-containing medicines - referral
  3. Ibuprofen product-specific bioequivalence guidance

What side effects are possible with Ruprofen?

Possible Side Effects and Safety Information

The official safety profile for Ruprofen, whose active ingredient is Ibuprofen (an NSAID), is defined by regulatory documents based on the body systems affected and the reaction frequency. The most commonly reported adverse reactions involve Gastrointestinal Disorders, such as dyspepsia, abdominal pain, nausea, and vomiting. However, the regulatory labels emphasize the potential for serious adverse reactions.


Documented Serious Adverse Reactions

Official documents warn of potentially fatal outcomes related to Gastrointestinal bleeding, ulceration, and perforation. Serious Cardiovascular Thrombotic Events, including myocardial infarction (MI) and stroke, are also documented risks, with the risk potentially increasing with longer use.

Severe Cutaneous Adverse Reactions (SCARs), such as Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN), are documented risks, with the highest risk often appearing early in the course of therapy.


Safety Considerations for Specific Populations

Safety constraints are noted for certain groups. Older adults face an increased risk and frequency of serious adverse effects, particularly fatal GI bleeding. Use is officially constrained for pregnant patients after 20 weeks of gestation due to potential risks to the fetus. Furthermore, the official label notes that the medicine may mask the symptoms of infection, which could delay diagnosis.

If visual disturbances occur, regulatory documents state that the medication should be discontinued and an ophthalmological examination should be conducted. The use of Ruprofen may also be associated with the impairment of female fertility, an effect which is generally reversible upon cessation of treatment.

Overdose and Emergency Response

Overdose and When to Seek Help

This section details the officially documented manifestations of Ruprofen (Ibuprofen) overdose and the specific emergency actions mandated by government regulatory bodies.


Documented Clinical Manifestations

Official prescribing information documents a range of overdose signs, which are often an exaggeration of the medicine’s known effects. These include gastrointestinal disturbances such as nausea, vomiting, and epigastric pain, as well as Central Nervous System (CNS) effects like headache, drowsiness, dizziness, tinnitus, lethargy, and confusion. More severe outcomes may include convulsions, coma, and hypotension (low blood pressure).


Severe Outcomes and Emergency Actions

Regulators note the potential for serious complications, including severe gastrointestinal bleeding/perforation and acute renal failure. Urgent action is required for any suspected overdose.

  • Immediate Medical Attention: Individuals must seek emergency medical attention or call a Poison Help line immediately upon suspicion of overdose.
  • Management: There is no specific antidote for Ibuprofen. Management is primarily symptomatic and supportive, including correction of fluid imbalances. Administration of activated charcoal may be considered within the first hour for large ingestions. Hospital observation and monitoring are required for symptomatic patients.
  • Population Risk: There is an increased risk of renal impairment in dehydrated children and adolescents following Ibuprofen use.

Therapeutic Uses of Ruprofen

Ruprofen is commonly used in situations involving certain distressing symptoms, applied across domains where additional symptomatic support is needed, and is relevant for easing symptoms that interfere with daily functioning. The therapeutic use generally includes managing mild to moderate pain, fever, and inflammation associated with various conditions. The medication is used to help with symptoms related to physical discomfort and systemic imbalance.

It helps manage symptom clusters that may become intense or disruptive, such as common headaches, pain associated with minor dental procedures, elevated fever, and the stiffness and swelling related to chronic conditions like Osteoarthritis or acute injuries like sprains and strains.

“Ruprofen assists with maintaining functional stability by providing supportive relief when symptoms interfere with routine activities.”

Quick Fact: Relief for Pain and Inflammation

Ruprofen is commonly used across conditions presenting with acute episodes and those characterized by symptoms related to inflammatory or irritative states. It is applied in clinical settings that involve acute or unstable symptom patterns, such as flare-ups of Rheumatoid Arthritis or the discomfort of primary dysmenorrhea (menstrual pain). This contributes to improved comfort during periods of heightened symptoms.

Eligibility and Restrictions for Use

This section outlines the eligibility and exclusion criteria for Ruprofen (ibuprofen), based strictly on official government regulatory documents.

Populations That Must Not Use Ruprofen (Contraindicated)

Condition / Population Exclusion Basis (Official Labeling)
Hypersensitivity Known allergy to ibuprofen, aspirin, or any other NSAID.
Active GI Pathology Active peptic ulcer, gastrointestinal bleeding, or perforation.
Severe Organ Failure Severe heart failure (e.g., NYHA Class IV), severe renal, or severe hepatic failure.
Late-Stage Pregnancy Starting at 20 weeks of gestation (third trimester risk).
Cardiac Surgery Treatment of peri-operative pain in the setting of Coronary Artery Bypass Graft (CABG) surgery.

Populations Requiring Caution (Conditional Use)

  • Elderly Patients: Require careful assessment and the lowest effective dose for the shortest duration due to increased risk of serious adverse events.
  • Patients with Pre-existing Disease: Those with uncontrolled hypertension, mild-to-moderate renal or hepatic impairment, or a history of gastrointestinal disease (e.g., Crohn’s, colitis).
  • High-Dose Use: Doses of 2400 mg/day or higher are generally not recommended for patients with established cardiovascular disease (e.g., ischemic heart disease) or associated risk factors.

Age-Related Eligibility

Ruprofen is generally approved for short-term use in adults and adolescents aged 12 years and older. Use in younger children is permitted with specific, weight-dependent pediatric formulations and often requires medical consultation.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents detail several critical interactions based on their documented effects on drug clearance and systemic risk. Co-administration of Ruprofen (Ibuprofen) with other Nonsteroidal Anti-inflammatory Drugs (NSAIDs) or Aspirin at daily doses above 75 mg is formally contraindicated due to a magnified risk of adverse gastrointestinal events.

Pharmacokinetic and Pharmacodynamic Interactions

Ruprofen may cause a pharmacokinetic interaction by reducing the renal clearance of substances like Lithium and Methotrexate, which increases their plasma concentrations and risk of toxicity. Conversely, co-administration with CYP2C9 inhibitors (e.g., Fluconazole) reduces Ibuprofen clearance, increasing its systemic exposure.

Pharmacodynamic interactions are documented with drugs that affect bleeding risk. Combining Ruprofen with Anticoagulants (e.g., Warfarin), Antiplatelet agents, or SSRIs/SNRIs significantly enhances the potential for bleeding. Co-administration with Alcohol or the herbal product Ginkgo biloba also carries a documented increased bleeding risk.

Administration Timing and Specific Populations

Due to potential interference with the antiplatelet effect of low-dose Aspirin, regulatory guidelines mandate a temporal separation rule for administration. Furthermore, official labeling notes that elderly patients face a heightened risk of adverse renal events when Ruprofen is combined with Diuretics or ACE-inhibitors.

Mechanism of Action

Ruprofen's mechanism of action is defined by its competitive and reversible inhibition of the Cyclooxygenase (COX) enzyme isoforms, COX-1 and COX-2. This non-selective blockade interferes with the first committed step of the Arachidonic Acid Pathway. The drug prevents the conversion of Arachidonic Acid into Prostaglandins ( PGE2) and other prostanoids. The active form, the S-enantiomer, achieves this molecular blockade, while the R-enantiomer is converted in vivo to sustain the overall inhibitory effect. Reduced prostaglandin synthesis alters signaling dynamics in key physiological systems. Peripherally, it dampens the chemical sensitization of nociceptors (pain-sensing neurons). Centrally, it reverses the elevation of the hypothalamic thermoregulatory set point. Because the inhibition is reversible, the functional modulation of pathway activity is transient and directly linked to the drug’s concentration at the enzyme target site.

Dosage and Administration Information

How to Use Ruprofen: Official Administration Guidelines

Ruprofen (Ibuprofen) is administered according to the guidelines specified in official prescribing information and product characteristics. These instructions define the proper route, dosing limits, frequency, and conditions for use.

Administration and Dosage Rules

The approved route of administration for Ruprofen tablets, capsules, and oral suspensions is oral.

Usage Constraint Official Rule
Standard Dosing Use the lowest effective dosage for the shortest duration necessary.
OTC/Self-Treatment Dose 200 mg to 400 mg per dose.
Maximum Adult Daily Dose Do not exceed 3200 mg (prescription) or 1200 mg (OTC) in a 24-hour period.
Dosing Frequency Doses are typically taken every 4 to 6 hours as needed.
Food Intake May be taken with meals or milk to reduce the potential for gastrointestinal irritation.

Special Population and Procedural Instructions

Pediatric Dosing is based on body weight, typically 5 to 10 mg/kg every 6 to 8 hours, with a maximum limit of 40 mg/kg/day. For liquid forms, the dose must be accurately measured using a dosing device provided with the product. OTC use for pain should generally not exceed 10 consecutive days without medical consultation. Additionally, specific dosage forms, such as modified-release tablets, must be swallowed whole and must not be crushed or chewed.

Recent Clinical Evidence

Ruprofen: Research Evidence Overview

The research foundation for Ruprofen (Ibuprofen) is substantial, as it is a substance recognized by major health agencies as a well-established substance. This evidence is generally composed of Randomized Controlled Trials (RCTs) that compare it to placebo or other common pain and fever agents, along with large-scale systematic reviews and meta-analyses synthesizing these trial results. The scope of this summary is limited to describing what was studied and what patterns were reported, without providing clinical interpretations or treatment guidance.


Research Examining Symptom Patterns in Acute Pain and Fever

Studies exploring Ruprofen's effects have employed various designs, including short-term, tightly controlled clinical trials and broader observational settings. The research primarily examined outcomes related to physical discomfort, outcomes related to systemic or functional imbalance, and outcomes linked to inflammatory or irritative states. The aim of these studies is to characterize the changes measured during the study period and contribute to the broader evidence landscape by describing group patterns.

For elevated body temperature (fever), short-term RCTs monitored outcomes related to physiological strain. Findings described patterns observed in the studies related to the speed and duration of the antipyretic effect. The evidence base for this area is described as High (coarse grading). For mild to moderate general pain, studies involved applying research examining patient-reported experiences of pain intensity, monitoring outcomes related to perceived discomfort over short, acute measurement periods.

Research Examining Specific Symptom Patterns

Ruprofen was studied for its use in examining acute discomfort following specific events, such as pain related to minor dental procedures and sprains and strains. These trials focused on short-term outcomes such as measures of pain score change and measures of change in daily functioning following injury. The research base for menstrual pain (primary dysmenorrhea) involves controlled clinical trials that monitored outcomes reflecting daily functioning or activity level during the menstrual cycle.


Research Gaps and Limitations

While evidence is substantial, research highlights what is still uncertain. Long-term effects are not fully established for all indications, as follow-up durations were short and often focused on acute episodes. Data for certain special groups, particularly for long-term outcomes in children or older adults with complex health profiles, remain insufficient. Furthermore, some evidence, particularly in chronic conditions like Osteoarthritis, does not determine whether Ruprofen alters the long-term structural progression of the condition.

Key Studies & References

  1. Efficacy and safety of ibuprofen and acetaminophen in children and adults: a meta-analysis and qualitative review

Frequently Asked Questions (FAQ)

Common questions about Ruprofen (FAQ)


Q: Is Ruprofen the same kind of medicine as Advil or Tylenol?

Ruprofen contains the active ingredient Ibuprofen, which is classified as a Nonsteroidal Anti-inflammatory Drug (NSAID). According to pharmacological classification, this is a different type of medicine than acetaminophen, commonly known as Tylenol. Acetaminophen is classified as an analgesic (pain reliever) and antipyretic (fever reducer) but does not belong to the NSAID group.


Q: Does Ruprofen interact with common vitamins or supplements?

Official product information notes a documented interaction where combining Ruprofen with the herbal product Ginkgo biloba carries an increased risk of bleeding. Regulatory documents detail specific drug-drug interactions, but generally do not list every common vitamin. Official guidelines recommend that patients discuss the use of all supplements with a healthcare professional.


Q: What is the difference between Ruprofen and other anti-inflammatory drugs?

Ruprofen is classified as an NSAID, a drug class that works by interfering with the body's production of prostaglandins—the chemical messengers involved in pain and inflammation. Other types of anti-inflammatory medications, such as corticosteroids, use different molecular mechanisms to achieve their anti-inflammatory effect.


Q: How long does one dose of Ruprofen last in your system?

Official pharmacokinetic data indicates that the half-life of Ibuprofen is typically between 2 and 4 hours. The half-life refers to the time it takes for the amount of drug in the body to decrease by half. The frequency of dosing is determined by the duration of the effect.


Q: What does the term 'contraindication' mean regarding Ruprofen?

A contraindication is a term used in official medical texts to describe a condition or factor that absolutely prevents the use of a medicine because of the harm it could cause. For Ruprofen, the contraindications listed on the label identify specific, serious health circumstances where the drug must not be used, such as severe organ failure.


Q: What types of food should be avoided while on Ruprofen?

Official product information states that Ruprofen may be taken with food or milk to reduce the potential for stomach irritation. However, regulatory documents note a documented increased risk of bleeding when the drug is combined with alcohol. No specific general foods are listed for avoidance.


Q: What does 'Black Box Warning' mean for Ruprofen?

A Boxed Warning (sometimes called a 'Black Box Warning') is the strongest safety warning required by the FDA to call attention to serious or life-threatening risks. For this class of drug, the warning alerts users and prescribers to the documented potential for serious Cardiovascular Thrombotic Events and Gastrointestinal bleeding.


Q: Is it safe to drive after taking Ruprofen?

Official labeling includes documented potential adverse effects such as dizziness, drowsiness, and visual disturbances. Patients experiencing these effects are cautioned that they may affect their ability to drive or operate machinery safely.


Q: What is Ruprofen actually used for besides the main thing?

According to official regulatory documents, Ruprofen is indicated for purposes beyond general pain and fever relief. These include the relief of signs and symptoms related to certain inflammatory conditions, such as rheumatoid arthritis and osteoarthritis. It is also indicated for the management of primary dysmenorrhea, which is defined as menstrual pain.


Q: How long does it typically take for Ruprofen to start working?

Official pharmacokinetic data indicates that the onset of action for pain relief generally occurs within 30 minutes following oral administration of the drug. The exact time may vary based on the specific formulation.


Q: Can Ruprofen cause me to feel dizzy or tired?

Yes, official safety documents list both dizziness and drowsiness as documented side effects reported in clinical practice and post-marketing surveillance. This type of reaction may also affect alertness.


Q: Is there a generic version of Ruprofen available?

Yes, the active ingredient in Ruprofen, which is Ibuprofen, is a widely available compound. This means that Ibuprofen is available as a generic drug from multiple manufacturers, in addition to various brand-name products.


Q: Can Ruprofen affect my sleep schedule?

Official safety documents list drowsiness as a documented adverse reaction. This is an effect that may influence a person's sleep patterns or ability to concentrate while awake.


Q: What happens if I stop taking Ruprofen suddenly?

Regulatory documentation does not list any withdrawal symptoms associated with the abrupt discontinuation of Ruprofen. This is consistent with its classification as a Nonsteroidal Anti-inflammatory Drug (NSAID).


Q: Is it normal to have a slight headache after starting Ruprofen?

Official labeling notes that headache is listed as a documented adverse reaction reported in clinical practice. The occurrence of side effects can vary among individuals.


Q: Does taking Ruprofen affect the results of lab tests?

Official labeling documents note that Ibuprofen may lead to false-positive results for urinary screening tests for tetrahydrocannabinol (THC). It may also affect some laboratory values related to liver and renal function.


Q: What if I forget to take a dose of Ruprofen?

Official patient information often describes a common approach for missed doses, which is to take the dose when remembered unless it is almost time for the next scheduled dose. This approach aims to prevent taking excess medicine.


Q: Is Ruprofen linked to any mental health side effects, like anxiety?

Yes, the official European Summary of Product Characteristics (SmPC) lists psychiatric disorders such as anxiety and insomnia as documented, although rare, adverse reactions. These potential effects are monitored through official surveillance.


Q: Is Ruprofen safe to use if I have asthma?

Official regulatory labeling indicates that Ruprofen is contraindicated for use in patients who have experienced asthma or other allergic-type reactions after taking aspirin or other NSAIDs. The risk of 'aspirin-sensitive asthma' is specifically noted.


Q: How is Ruprofen eliminated from the body?

Ibuprofen is primarily metabolized in the liver (hepatic metabolism). It is then largely eliminated from the body via the kidneys (renal excretion) as inactive metabolites.


Q: Does Ruprofen cause weight gain or loss?

Official labeling notes that fluid retention and edema (swelling) have been reported in association with NSAID therapy. These effects may result in temporary changes to body weight.


Q: Is Ruprofen studied for uses outside of its current approval?

The research base for Ibuprofen is substantial and continuous. While the official labeling details approved uses, studies continue to examine the drug’s role in various conditions, including specific inflammatory disorders.


Q: Can I take Ruprofen if I am on hormonal birth control?

Official regulatory documents do not list an interaction between Ibuprofen and common hormonal contraceptives that would reduce the contraceptive's effectiveness. Interactions are typically noted only when effectiveness is impacted.


Q: Does Ruprofen have a risk of addiction?

Ruprofen is classified as a Nonsteroidal Anti-inflammatory Drug (NSAID) and is not listed as a controlled substance by regulatory agencies. This classification indicates that it does not carry a risk of physical dependence or addiction.


Q: How often do people typically experience severe side effects from Ruprofen?

Regulatory documents categorize serious adverse reactions, such as severe gastrointestinal bleeding or cardiovascular events, as uncommon (occurring in 1 in 100 to 1 in 1,000 users) or rare events. Official labeling notes that the risk is potentially higher with longer use of the medication.

How should Ruprofen be stored and disposed of?

Official Storage and Disposal Requirements

Official regulatory documents define specific conditions for storing and disposing of this medication to maintain its stability and safety. The drug must be stored at controlled room temperature, typically below 25°C or 30°C, and should be kept away from excessive heat, moisture, and light. It is mandatory to store the medicine in its original, tightly closed container and out of the sight and reach of children.

For single-use products, such as injections, any opened solution must be used immediately and any unused portion discarded. When disposing of unused or expired medicine, regulatory agencies require using official drug take-back programs or following local guidelines for safe household disposal, which includes mixing the medicine with an undesirable substance, sealing it, and discarding it in the trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Ruprofen found in:

A-Z Index: